NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
For all prescribers and health professionals both in primary care and the acute sector.
Please note, Medicines Update blogs are correct at the time of publication.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
We would like to hear what you think of Medicines Update blogs. Please leave us your feedback using this anonymous survey here
Posted: October 11, 2019.
Category - Medicines Update
This post summarise the guidelines that have changed in the most recent content update to the Adult Therapeutics Handbook
Posted: October 04, 2019.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: September 26, 2019.
Category - Medicines Update
Semglee® – preferred brand of INSULIN GLARGINE The patent for insulin glargine 100 units/ml (Lantus®) has expired. Biosim...
Posted: September 23, 2019.
Category - Medicines Update
https://www.choiceandmedication.org/nhs24/ Choice and medication is a free resource hosted within NHS Inform for use in NHS Scotland that provides u...
Posted: September 17, 2019.
Category - Medicines Update
Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome Following an EU review, the Summary of Product Characteristics (...
Posted: September 16, 2019.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: September 09, 2019.
Category - Medicines Update
Key Messages Generic prescribing is usually recommended due to cost-effectiveness, however in certain circumstances it is important to prescribe medication by brand name Examples of medication to be pre...
Posted: September 09, 2019.
Category - Medicines Update
Semaglutide is a new weekly injectable glucagon-like peptide-1 (GLP-1) agonist recently added to formulary. It is available as a single pen device with 4 doses providing the patient with all they require for a month.
Posted: August 23, 2019.
Category - Medicines Update
Nicotine Replacement Therapy (NRT): Formulary choices Key messages Nicotinell® products (24-hour patches, lozenges or ...
Posted: August 19, 2019.
Category - Medicines Update
The Adult Therapeutics Handbook content has now been updated. The following guidelines have had minor content updates: